4.6 Article

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

期刊

MOVEMENT DISORDERS
卷 27, 期 3, 页码 349-356

出版社

WILEY
DOI: 10.1002/mds.24893

关键词

Parkinson's disease; cognition; mild cognitive impairment; diagnostic criteria; dementia

资金

  1. Medtronic
  2. GlaxoSmithKline
  3. National Parkinson Foundation
  4. National Institutes of Health [P50 AG016574, U01 AG006786, NS36630, RR024156]
  5. Parkinson's UK
  6. European Union
  7. Child Health and Development Institute
  8. Michael J. Fox Foundation for Parkinson's Research
  9. Teva Lundbeck
  10. Springer
  11. MRC [G0800784] Funding Source: UKRI
  12. Medical Research Council [G0800784, G0800784B] Funding Source: researchfish

向作者/读者索取更多资源

Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a harbinger of dementia. In view of its importance, the Movement Disorder Society commissioned a task force to delineate diagnostic criteria for mild cognitive impairment in PD. The proposed diagnostic criteria are based on a literature review and expert consensus. This article provides guidelines to characterize the clinical syndrome and methods for its diagnosis. The criteria will require validation, and possibly refinement, as additional research improves our understanding of the epidemiology, presentation, neurobiology, assessment, and long-term course of this clinical syndrome. These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage. (c) 2012 Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据